Magnitude Biosciences Ltd performed whole-organism RNAseq on C. elegans treated with Compound X to understand its molecular basis.
Public source
Publisher name
Public post
This week, we conclude our end-to-end Case Study series, 📚 ➜🎯 ➜ 💊 From Library to Molecule For companies sitting on a #compoundlibrary in need of #repurposing, this o…
Company
Magnitude Biosciences Ltd
Accelerating R&D with In Vivo C. elegans Data & WormGazer® Technology, De-Risking Clinical Trials and Cutting Costs
- Industry
- Biotechnology Research
- Location
- Durham, GB
- Company size
- 11–50 employees
About Magnitude Biosciences Ltd
An innovative C. elegans company, using our expertise and technology to provide quantified non-invasive assays of health outcomes for biotech, nutrition and other industries and research interests. - Prescreen compounds to reduce the number of experiments in mammals - Find effective and safe concentration ranges - Test mutants in signalling pathways - Screen libraries of mutants - Screen compound libraries - Combine compounds and mutants - Adapt technology to address your questions We are a team of experts with a proven track record of: Designing customised C. elegans studies to provide answers to your specific ageing research questions Integrating C. elegans into drug discovery pipelines Working with innovative biotech and pharma companies Providing relevant, standardised, data rich assays
See moreLatest activity
Latest activity from Magnitude Biosciences Ltd
8 signals
Presence & Recognition
Magnitude Biosciences Ltd is a sponsor of the 75th Annual Scientific Meeting of the British Society for Research on Ageing (BSRA) at Keble College, Oxford, from 9 to 11 September 2026, with Principal Scientist Dr Karthik Mohanraj attending.
Research & Knowledge
Magnitude Biosciences Ltd used the VivoScan whole-organism phenotypic screening platform to test lifespan-extending effects of Urolithin A in a wide range of concentrations.
Research & Knowledge
Magnitude Biosciences Ltd tested Urolithin A on WormGazer and found that its beneficial effects extended into overall organismal healthspan, preserving the quality of worms' mobility well into adulthood.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
DARWIN Bioprospecting Excellence
DARWIN Bioprospecting Excellence published a study by researchers using C. elegans as an ageing model to test how a specific magnetic bacterium increases lifespan.
Research & Knowledge
MD Biosciences Neuro
MD Biosciences Neuro runs neurodegeneration screening on primary neurons across Parkinson's, Alzheimer's, chemotherapy induced neuropathy, and diabetes, scored with a quantitative neurodegeneration index.
Research & Knowledge
Tecan
Tecan's team conducted its largest-ever drug screen testing 283 antioxidant compounds for RCBTB1-associated retinopathy using iPSC-derived retinal cells, multimodal imaging, and luminescence analysis.
Research & Knowledge
Single Cell Discoveries
Single Cell Discoveries contributed to a project exploring the potential of natural compounds using Discovery-seq.
Research & Knowledge
Fios Genomics